These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 32500793)

  • 1. Repurposing Nimesulide, a Potent Inhibitor of the B0AT1 Subunit of the SARS-CoV-2 Receptor, as a Therapeutic Adjuvant of COVID-19.
    Scalise M; Indiveri C
    SLAS Discov; 2020 Dec; 25(10):1171-1173. PubMed ID: 32500793
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Contributions of human ACE2 and TMPRSS2 in determining host-pathogen interaction of COVID-19.
    Senapati S; Banerjee P; Bhagavatula S; Kushwaha PP; Kumar S
    J Genet; 2021; 100(1):. PubMed ID: 33707363
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Screened antipsychotic drugs inhibit SARS-CoV-2 binding with ACE2 in vitro.
    Lu J; Hou Y; Ge S; Wang X; Wang J; Hu T; Lv Y; He H; Wang C
    Life Sci; 2021 Feb; 266():118889. PubMed ID: 33310043
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ACE2 and gut amino acid transport.
    Camargo SMR; Vuille-Dit-Bille RN; Meier CF; Verrey F
    Clin Sci (Lond); 2020 Nov; 134(21):2823-2833. PubMed ID: 33140827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SARS-CoV-2 (COVID-19) structural and evolutionary dynamicome: Insights into functional evolution and human genomics.
    Gupta R; Charron J; Stenger CL; Painter J; Steward H; Cook TW; Faber W; Frisch A; Lind E; Bauss J; Li X; Sirpilla O; Soehnlen X; Underwood A; Hinds D; Morris M; Lamb N; Carcillo JA; Bupp C; Uhal BD; Rajasekaran S; Prokop JW
    J Biol Chem; 2020 Aug; 295(33):11742-11753. PubMed ID: 32587094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B
    Stevens BR; Ellory JC; Preston RL
    Function (Oxf); 2021; 2(4):zqab027. PubMed ID: 34847569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Repurposed ACE2 Inhibitors: SARS-CoV-2 Entry Blockers of Covid-19.
    Ahmad I; Pawara R; Surana S; Patel H
    Top Curr Chem (Cham); 2021 Oct; 379(6):40. PubMed ID: 34623536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidisciplinary Approaches Identify Compounds that Bind to Human ACE2 or SARS-CoV-2 Spike Protein as Candidates to Block SARS-CoV-2-ACE2 Receptor Interactions.
    Day CJ; Bailly B; Guillon P; Dirr L; Jen FE; Spillings BL; Mak J; von Itzstein M; Haselhorst T; Jennings MP
    mBio; 2021 Mar; 12(2):. PubMed ID: 33785634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Target-Centered Drug Repurposing Predictions of Human Angiotensin-Converting Enzyme 2 (ACE2) and Transmembrane Protease Serine Subtype 2 (TMPRSS2) Interacting Approved Drugs for Coronavirus Disease 2019 (COVID-19) Treatment through a Drug-Target Interaction Deep Learning Model.
    Choi Y; Shin B; Kang K; Park S; Beck BR
    Viruses; 2020 Nov; 12(11):. PubMed ID: 33218024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Molecular screening of glycyrrhizin-based inhibitors against ACE2 host receptor of SARS-CoV-2.
    Ahmad S; Waheed Y; Abro A; Abbasi SW; Ismail S
    J Mol Model; 2021 Jun; 27(7):206. PubMed ID: 34169390
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Nimesulide binding site in the B0AT1 (SLC6A19) amino acid transporter. Mechanism of inhibition revealed by proteoliposome transport assay and molecular modelling.
    Pochini L; Seidita A; Sensi C; Scalise M; Eberini I; Indiveri C
    Biochem Pharmacol; 2014 Jun; 89(3):422-30. PubMed ID: 24704252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epithelial and Endothelial Expressions of ACE2: SARS-CoV-2 Entry Routes.
    Guney C; Akar F
    J Pharm Pharm Sci; 2021; 24():84-93. PubMed ID: 33626315
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Different compounds against Angiotensin-Converting Enzyme 2 (ACE2) receptor potentially containing the infectivity of SARS-CoV-2: an in silico study.
    Shahbazi B; Mafakher L; Teimoori-Toolabi L
    J Mol Model; 2022 Mar; 28(4):82. PubMed ID: 35249180
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SARS-CoV-2 entry inhibitors by dual targeting TMPRSS2 and ACE2: An in silico drug repurposing study.
    Baby K; Maity S; Mehta CH; Suresh A; Nayak UY; Nayak Y
    Eur J Pharmacol; 2021 Apr; 896():173922. PubMed ID: 33539819
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low temperature bacterial expression of the neutral amino acid transporters SLC1A5 (ASCT2), and SLC6A19 (B0AT1).
    Galluccio M; Pantanella M; Giudice D; Brescia S; Indiveri C
    Mol Biol Rep; 2020 Sep; 47(9):7283-7289. PubMed ID: 32772343
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Withanone from
    Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A
    Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tinocordiside from
    Balkrishna A; Pokhrel S; Varshney A
    Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Repositioning of histamine H
    Ge S; Wang X; Hou Y; Lv Y; Wang C; He H
    Eur J Pharmacol; 2021 Apr; 896():173897. PubMed ID: 33497607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of S-protein RBD and hACE2 Interaction for Control of SARSCoV- 2 Infection (COVID-19).
    Nayak SK
    Mini Rev Med Chem; 2021; 21(6):689-703. PubMed ID: 33208074
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can Host Cell Proteins Like ACE2, ADAM17, TMPRSS2, Androgen Receptor be the Efficient Targets in SARS-CoV-2 Infection?
    Gupta VK; Murthy MK; Patil S
    Curr Drug Targets; 2021; 22(10):1149-1157. PubMed ID: 33243116
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.